Regulation of Inflammatory Genes in Psoriasis



Status:Recruiting
Conditions:Psoriasis
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:19 - 99
Updated:5/11/2018
Start Date:April 22, 2014
End Date:April 28, 2020

Use our guide to learn which trials are right for you!

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory
changes in the skin. An extensive cytokine network including generated by activated dendritic
cells and T cells mediates the formation of psoriatic lesions. These immune-response
parameters can be used as markers in the severity and management of the disease after further
in-depth studies.


Inclusion Criteria:

- Clinical diagnosis of psoriasis

- Must be age 19 or older.

- Must be Fitzpatrick skin type I, II, III, IV, V, VI.

Exclusion Criteria:

- Subjects who do not have photosensitive disease and are not on photosensitizing
medications.

- Subjects with a history of keloids (who are more likely to develop hypertrophic scars
following skin biopsy).

- Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.

- Subjects who are pregnant.
We found this trial at
1
site
Birmingham, Alabama 35233
Phone: 205-502-9960
?
mi
from
Birmingham, AL
Click here to add this to my saved trials